MAPK7 and prostate carcinoma: β1-integrin signaling via the vitronectin (VN) receptors increased FAK and ERK5 activation and promoted TNBC and prostate cancer cell adhesion to the ECM and micromotion in vitro [77] Adhesion of cancer cells to ECM was inhibited in the presence of VN blocking antibodies [77].